[1/4] Excel → CSV 변환 중...
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ratio: data/sample/TOX21_ERa_BLA_Antagonist_ratio.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist: data/sample/TOX21_ERa_LUC_VM7_Agonist.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_viability: data/sample/TOX21_ERa_BLA_Antagonist_viability.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ch2: data/sample/TOX21_ERa_BLA_Antagonist_ch2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ch1: data/sample/TOX21_ERa_BLA_Antagonist_ch1.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ch2: data/sample/TOX21_ERa_BLA_Agonist_ch2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ch1: data/sample/TOX21_ERa_BLA_Agonist_ch1.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ratio: data/sample/TOX21_ERa_BLA_Agonist_ratio.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ch1: data/sample/TOX21_ERb_BLA_Antagonist_ch1.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ch2: data/sample/TOX21_ERb_BLA_Antagonist_ch2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_viability: data/sample/TOX21_ERb_BLA_Agonist_viability.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ratio: data/sample/TOX21_ERb_BLA_Agonist_ratio.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ch2: data/sample/TOX21_ERb_BLA_Agonist_ch2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ch1: data/sample/TOX21_ERb_BLA_Agonist_ch1.csv
Saved pretrain CSV for TOX21_ERR_LUC_Agonist: data/sample/TOX21_ERR_LUC_Agonist.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ratio: data/sample/TOX21_ERb_BLA_Antagonist_ratio.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780.csv
Saved pretrain CSV for TOX21_ERR_LUC_viability: data/sample/TOX21_ERR_LUC_viability.csv
Saved pretrain CSV for TOX21_ERR_LUC_Antagonist: data/sample/TOX21_ERR_LUC_Antagonist.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_viability: data/sample/TOX21_ERb_BLA_Antagonist_viability.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ratio: data/sample/TOX21_ERa_BLA_Antagonist_ratio.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist: data/sample/TOX21_ERa_LUC_VM7_Agonist.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_viability: data/sample/TOX21_ERa_BLA_Antagonist_viability.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ch2: data/sample/TOX21_ERa_BLA_Antagonist_ch2.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ch1: data/sample/TOX21_ERa_BLA_Antagonist_ch1.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ch2: data/sample/TOX21_ERa_BLA_Agonist_ch2.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ch1: data/sample/TOX21_ERa_BLA_Agonist_ch1.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ratio: data/sample/TOX21_ERa_BLA_Agonist_ratio.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ch1: data/sample/TOX21_ERb_BLA_Antagonist_ch1.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ch2: data/sample/TOX21_ERb_BLA_Antagonist_ch2.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_viability: data/sample/TOX21_ERb_BLA_Agonist_viability.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ratio: data/sample/TOX21_ERb_BLA_Agonist_ratio.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ch2: data/sample/TOX21_ERb_BLA_Agonist_ch2.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ch1: data/sample/TOX21_ERb_BLA_Agonist_ch1.csv
Saved finetune CSV for TOX21_ERR_LUC_Agonist: data/sample/TOX21_ERR_LUC_Agonist.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ratio: data/sample/TOX21_ERb_BLA_Antagonist_ratio.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780.csv
Saved finetune CSV for TOX21_ERR_LUC_viability: data/sample/TOX21_ERR_LUC_viability.csv
Saved finetune CSV for TOX21_ERR_LUC_Antagonist: data/sample/TOX21_ERR_LUC_Antagonist.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_viability: data/sample/TOX21_ERb_BLA_Antagonist_viability.csv
[2/4] Pretraining on TOX21_ERa_BLA_Antagonist_ratio using GIN_GCN...
Epoch 1/50 - Loss: 0.6203 - Val F1: 0.3636 - Val ROC-AUC: 0.7389 - Val PR-AUC: 0.2967
Epoch 2/50 - Loss: 0.5828 - Val F1: 0.3597 - Val ROC-AUC: 0.7664 - Val PR-AUC: 0.2927
Epoch 3/50 - Loss: 0.5688 - Val F1: 0.3822 - Val ROC-AUC: 0.7813 - Val PR-AUC: 0.3169
Epoch 4/50 - Loss: 0.5501 - Val F1: 0.3671 - Val ROC-AUC: 0.7797 - Val PR-AUC: 0.3200
Epoch 5/50 - Loss: 0.5396 - Val F1: 0.3596 - Val ROC-AUC: 0.7708 - Val PR-AUC: 0.3308
Epoch 6/50 - Loss: 0.5412 - Val F1: 0.4085 - Val ROC-AUC: 0.7920 - Val PR-AUC: 0.3332
Epoch 7/50 - Loss: 0.5300 - Val F1: 0.3721 - Val ROC-AUC: 0.7751 - Val PR-AUC: 0.3357
Epoch 8/50 - Loss: 0.5136 - Val F1: 0.4130 - Val ROC-AUC: 0.7905 - Val PR-AUC: 0.3350
Epoch 9/50 - Loss: 0.5062 - Val F1: 0.3929 - Val ROC-AUC: 0.7982 - Val PR-AUC: 0.3895
Epoch 10/50 - Loss: 0.5130 - Val F1: 0.4193 - Val ROC-AUC: 0.7911 - Val PR-AUC: 0.3343
Epoch 11/50 - Loss: 0.4857 - Val F1: 0.4075 - Val ROC-AUC: 0.7913 - Val PR-AUC: 0.3756
Epoch 12/50 - Loss: 0.4671 - Val F1: 0.4010 - Val ROC-AUC: 0.8038 - Val PR-AUC: 0.3730
Epoch 13/50 - Loss: 0.4640 - Val F1: 0.4129 - Val ROC-AUC: 0.8085 - Val PR-AUC: 0.3783
Epoch 14/50 - Loss: 0.4593 - Val F1: 0.3775 - Val ROC-AUC: 0.8003 - Val PR-AUC: 0.3850
Epoch 15/50 - Loss: 0.4576 - Val F1: 0.4116 - Val ROC-AUC: 0.8100 - Val PR-AUC: 0.4111
Epoch 16/50 - Loss: 0.4510 - Val F1: 0.4171 - Val ROC-AUC: 0.8104 - Val PR-AUC: 0.3877
Epoch 17/50 - Loss: 0.4443 - Val F1: 0.4175 - Val ROC-AUC: 0.8131 - Val PR-AUC: 0.3854
Epoch 18/50 - Loss: 0.4411 - Val F1: 0.4257 - Val ROC-AUC: 0.8002 - Val PR-AUC: 0.3849
Epoch 19/50 - Loss: 0.4318 - Val F1: 0.4224 - Val ROC-AUC: 0.7986 - Val PR-AUC: 0.3889
Epoch 20/50 - Loss: 0.4386 - Val F1: 0.4327 - Val ROC-AUC: 0.8212 - Val PR-AUC: 0.3979
Epoch 21/50 - Loss: 0.3976 - Val F1: 0.4536 - Val ROC-AUC: 0.8265 - Val PR-AUC: 0.3950
Epoch 22/50 - Loss: 0.4093 - Val F1: 0.4588 - Val ROC-AUC: 0.8253 - Val PR-AUC: 0.4128
Epoch 23/50 - Loss: 0.3978 - Val F1: 0.4483 - Val ROC-AUC: 0.8222 - Val PR-AUC: 0.3974
Epoch 24/50 - Loss: 0.3932 - Val F1: 0.4431 - Val ROC-AUC: 0.8302 - Val PR-AUC: 0.4045
Epoch 25/50 - Loss: 0.3898 - Val F1: 0.4472 - Val ROC-AUC: 0.8148 - Val PR-AUC: 0.3942
Epoch 26/50 - Loss: 0.3780 - Val F1: 0.4545 - Val ROC-AUC: 0.8311 - Val PR-AUC: 0.4222
Epoch 27/50 - Loss: 0.3728 - Val F1: 0.4437 - Val ROC-AUC: 0.8142 - Val PR-AUC: 0.3853
Epoch 28/50 - Loss: 0.3672 - Val F1: 0.4229 - Val ROC-AUC: 0.8152 - Val PR-AUC: 0.3982
Epoch 29/50 - Loss: 0.3728 - Val F1: 0.4358 - Val ROC-AUC: 0.8120 - Val PR-AUC: 0.3838
Epoch 30/50 - Loss: 0.3880 - Val F1: 0.4464 - Val ROC-AUC: 0.8311 - Val PR-AUC: 0.4388
Epoch 31/50 - Loss: 0.3505 - Val F1: 0.4364 - Val ROC-AUC: 0.8096 - Val PR-AUC: 0.3881
Epoch 32/50 - Loss: 0.3510 - Val F1: 0.4340 - Val ROC-AUC: 0.8125 - Val PR-AUC: 0.3959
Epoch 33/50 - Loss: 0.3535 - Val F1: 0.4561 - Val ROC-AUC: 0.8214 - Val PR-AUC: 0.3980
Epoch 34/50 - Loss: 0.3378 - Val F1: 0.4308 - Val ROC-AUC: 0.8148 - Val PR-AUC: 0.4008
Epoch 35/50 - Loss: 0.3394 - Val F1: 0.4370 - Val ROC-AUC: 0.8170 - Val PR-AUC: 0.3952
Epoch 36/50 - Loss: 0.3347 - Val F1: 0.4419 - Val ROC-AUC: 0.8189 - Val PR-AUC: 0.4066
Epoch 37/50 - Loss: 0.3384 - Val F1: 0.4305 - Val ROC-AUC: 0.8099 - Val PR-AUC: 0.4006
Epoch 38/50 - Loss: 0.3313 - Val F1: 0.4294 - Val ROC-AUC: 0.8095 - Val PR-AUC: 0.3859
Epoch 39/50 - Loss: 0.3290 - Val F1: 0.4437 - Val ROC-AUC: 0.8151 - Val PR-AUC: 0.4026
Epoch 40/50 - Loss: 0.3214 - Val F1: 0.4332 - Val ROC-AUC: 0.8105 - Val PR-AUC: 0.4025
Epoch 41/50 - Loss: 0.3273 - Val F1: 0.4411 - Val ROC-AUC: 0.8102 - Val PR-AUC: 0.4029
Epoch 42/50 - Loss: 0.3200 - Val F1: 0.4620 - Val ROC-AUC: 0.8157 - Val PR-AUC: 0.3954
Epoch 43/50 - Loss: 0.2968 - Val F1: 0.4539 - Val ROC-AUC: 0.8170 - Val PR-AUC: 0.3926
Epoch 44/50 - Loss: 0.3079 - Val F1: 0.4403 - Val ROC-AUC: 0.8132 - Val PR-AUC: 0.3941
Epoch 45/50 - Loss: 0.3139 - Val F1: 0.4291 - Val ROC-AUC: 0.8047 - Val PR-AUC: 0.3847
Epoch 46/50 - Loss: 0.3102 - Val F1: 0.4415 - Val ROC-AUC: 0.8075 - Val PR-AUC: 0.3875
Epoch 47/50 - Loss: 0.2987 - Val F1: 0.4430 - Val ROC-AUC: 0.8085 - Val PR-AUC: 0.3989
Epoch 48/50 - Loss: 0.2959 - Val F1: 0.4286 - Val ROC-AUC: 0.8070 - Val PR-AUC: 0.3923
Epoch 49/50 - Loss: 0.3156 - Val F1: 0.4487 - Val ROC-AUC: 0.8080 - Val PR-AUC: 0.3891
Epoch 50/50 - Loss: 0.2942 - Val F1: 0.4560 - Val ROC-AUC: 0.8055 - Val PR-AUC: 0.3885
Pretraining completed. Test F1: 0.4053, ROC-AUC: 0.7937, PR-AUC: 0.3179
[3/4] Finetuning on TOX21_ERa_BLA_Antagonist_viability using GIN_GCN...
[Fine-tune] Epoch 1/50 - Loss: 0.3811 - Val F1: 0.2113 - Val ROC-AUC: 0.8168 - Val PR-AUC: 0.2472
[Fine-tune] Epoch 2/50 - Loss: 0.3322 - Val F1: 0.1730 - Val ROC-AUC: 0.7765 - Val PR-AUC: 0.1544
[Fine-tune] Epoch 3/50 - Loss: 0.3044 - Val F1: 0.1789 - Val ROC-AUC: 0.8064 - Val PR-AUC: 0.1816
[Fine-tune] Epoch 4/50 - Loss: 0.2706 - Val F1: 0.2029 - Val ROC-AUC: 0.8145 - Val PR-AUC: 0.2014
[Fine-tune] Epoch 5/50 - Loss: 0.2662 - Val F1: 0.1803 - Val ROC-AUC: 0.7821 - Val PR-AUC: 0.1566
[Fine-tune] Epoch 6/50 - Loss: 0.2452 - Val F1: 0.1765 - Val ROC-AUC: 0.7917 - Val PR-AUC: 0.2816
[Fine-tune] Epoch 7/50 - Loss: 0.2332 - Val F1: 0.1965 - Val ROC-AUC: 0.7864 - Val PR-AUC: 0.1666
[Fine-tune] Epoch 8/50 - Loss: 0.2220 - Val F1: 0.1865 - Val ROC-AUC: 0.8147 - Val PR-AUC: 0.2074
[Fine-tune] Epoch 9/50 - Loss: 0.1998 - Val F1: 0.1931 - Val ROC-AUC: 0.8331 - Val PR-AUC: 0.1682
[Fine-tune] Epoch 10/50 - Loss: 0.2024 - Val F1: 0.2143 - Val ROC-AUC: 0.7960 - Val PR-AUC: 0.1633
[Fine-tune] Epoch 11/50 - Loss: 0.1640 - Val F1: 0.2205 - Val ROC-AUC: 0.8191 - Val PR-AUC: 0.1771
[Fine-tune] Epoch 12/50 - Loss: 0.1586 - Val F1: 0.2564 - Val ROC-AUC: 0.8274 - Val PR-AUC: 0.2584
[Fine-tune] Epoch 13/50 - Loss: 0.1335 - Val F1: 0.1846 - Val ROC-AUC: 0.8105 - Val PR-AUC: 0.1665
[Fine-tune] Epoch 14/50 - Loss: 0.1523 - Val F1: 0.2202 - Val ROC-AUC: 0.8459 - Val PR-AUC: 0.1907
[Fine-tune] Epoch 15/50 - Loss: 0.1233 - Val F1: 0.1905 - Val ROC-AUC: 0.8135 - Val PR-AUC: 0.2007
[Fine-tune] Epoch 16/50 - Loss: 0.1220 - Val F1: 0.2247 - Val ROC-AUC: 0.8207 - Val PR-AUC: 0.2649
[Fine-tune] Epoch 17/50 - Loss: 0.1229 - Val F1: 0.1880 - Val ROC-AUC: 0.7739 - Val PR-AUC: 0.2793
[Fine-tune] Epoch 18/50 - Loss: 0.1121 - Val F1: 0.2115 - Val ROC-AUC: 0.8171 - Val PR-AUC: 0.2569
[Fine-tune] Epoch 19/50 - Loss: 0.1110 - Val F1: 0.1600 - Val ROC-AUC: 0.8146 - Val PR-AUC: 0.2096
[Fine-tune] Epoch 20/50 - Loss: 0.1173 - Val F1: 0.2268 - Val ROC-AUC: 0.8158 - Val PR-AUC: 0.2889
[Fine-tune] Epoch 21/50 - Loss: 0.1019 - Val F1: 0.2529 - Val ROC-AUC: 0.8107 - Val PR-AUC: 0.2389
[Fine-tune] Epoch 22/50 - Loss: 0.0950 - Val F1: 0.2653 - Val ROC-AUC: 0.8306 - Val PR-AUC: 0.2237
[Fine-tune] Epoch 23/50 - Loss: 0.0942 - Val F1: 0.2353 - Val ROC-AUC: 0.8158 - Val PR-AUC: 0.2410
[Fine-tune] Epoch 24/50 - Loss: 0.0763 - Val F1: 0.2316 - Val ROC-AUC: 0.8164 - Val PR-AUC: 0.3152
[Fine-tune] Epoch 25/50 - Loss: 0.0781 - Val F1: 0.2750 - Val ROC-AUC: 0.8253 - Val PR-AUC: 0.2435
[Fine-tune] Epoch 26/50 - Loss: 0.0837 - Val F1: 0.2529 - Val ROC-AUC: 0.8256 - Val PR-AUC: 0.2483
[Fine-tune] Epoch 27/50 - Loss: 0.0775 - Val F1: 0.2316 - Val ROC-AUC: 0.8098 - Val PR-AUC: 0.2406
[Fine-tune] Epoch 28/50 - Loss: 0.0868 - Val F1: 0.2424 - Val ROC-AUC: 0.8049 - Val PR-AUC: 0.2170
[Fine-tune] Epoch 29/50 - Loss: 0.0702 - Val F1: 0.2469 - Val ROC-AUC: 0.8135 - Val PR-AUC: 0.2192
[Fine-tune] Epoch 30/50 - Loss: 0.0703 - Val F1: 0.2973 - Val ROC-AUC: 0.8063 - Val PR-AUC: 0.2505
[Fine-tune] Epoch 31/50 - Loss: 0.0629 - Val F1: 0.2750 - Val ROC-AUC: 0.7970 - Val PR-AUC: 0.2410
[Fine-tune] Epoch 32/50 - Loss: 0.0669 - Val F1: 0.2821 - Val ROC-AUC: 0.7954 - Val PR-AUC: 0.2170
[Fine-tune] Epoch 33/50 - Loss: 0.0516 - Val F1: 0.2716 - Val ROC-AUC: 0.8094 - Val PR-AUC: 0.2315
[Fine-tune] Epoch 34/50 - Loss: 0.0593 - Val F1: 0.2564 - Val ROC-AUC: 0.8029 - Val PR-AUC: 0.2494
[Fine-tune] Epoch 35/50 - Loss: 0.0659 - Val F1: 0.2933 - Val ROC-AUC: 0.8205 - Val PR-AUC: 0.2228
[Fine-tune] Epoch 36/50 - Loss: 0.0566 - Val F1: 0.2895 - Val ROC-AUC: 0.8171 - Val PR-AUC: 0.2506
[Fine-tune] Epoch 37/50 - Loss: 0.0528 - Val F1: 0.2785 - Val ROC-AUC: 0.8286 - Val PR-AUC: 0.2657
[Fine-tune] Epoch 38/50 - Loss: 0.0665 - Val F1: 0.2750 - Val ROC-AUC: 0.8331 - Val PR-AUC: 0.2446
[Fine-tune] Epoch 39/50 - Loss: 0.0604 - Val F1: 0.2532 - Val ROC-AUC: 0.8196 - Val PR-AUC: 0.2260
[Fine-tune] Epoch 40/50 - Loss: 0.0561 - Val F1: 0.2821 - Val ROC-AUC: 0.8262 - Val PR-AUC: 0.2459
[Fine-tune] Epoch 41/50 - Loss: 0.0530 - Val F1: 0.2857 - Val ROC-AUC: 0.8239 - Val PR-AUC: 0.2419
[Fine-tune] Epoch 42/50 - Loss: 0.0525 - Val F1: 0.2933 - Val ROC-AUC: 0.8210 - Val PR-AUC: 0.2280
[Fine-tune] Epoch 43/50 - Loss: 0.0615 - Val F1: 0.2895 - Val ROC-AUC: 0.8339 - Val PR-AUC: 0.2381
[Fine-tune] Epoch 44/50 - Loss: 0.0543 - Val F1: 0.3056 - Val ROC-AUC: 0.8288 - Val PR-AUC: 0.2363
[Fine-tune] Epoch 45/50 - Loss: 0.0513 - Val F1: 0.2973 - Val ROC-AUC: 0.8281 - Val PR-AUC: 0.2357
[Fine-tune] Epoch 46/50 - Loss: 0.0508 - Val F1: 0.2933 - Val ROC-AUC: 0.8230 - Val PR-AUC: 0.2320
[Fine-tune] Epoch 47/50 - Loss: 0.0513 - Val F1: 0.2821 - Val ROC-AUC: 0.8287 - Val PR-AUC: 0.2343
[Fine-tune] Epoch 48/50 - Loss: 0.0539 - Val F1: 0.2785 - Val ROC-AUC: 0.8248 - Val PR-AUC: 0.2228
[Fine-tune] Epoch 49/50 - Loss: 0.0474 - Val F1: 0.2750 - Val ROC-AUC: 0.8276 - Val PR-AUC: 0.2562
[Fine-tune] Epoch 50/50 - Loss: 0.0477 - Val F1: 0.2895 - Val ROC-AUC: 0.8196 - Val PR-AUC: 0.2144
Finetuning completed. Test F1: 0.3284, ROC-AUC: 0.8280, PR-AUC: 0.2762
[3.1/4] Target-only training on TOX21_ERa_BLA_Antagonist_viability using GIN_GCN...
=== Target-only training ===
[Target-only] Epoch 1/50 – Loss: 0.5572  Val F1: 0.1050  ROC-AUC: 0.6940  PR-AUC: 0.0823
[Target-only] Epoch 2/50 – Loss: 0.4846  Val F1: 0.1220  ROC-AUC: 0.7226  PR-AUC: 0.2029
[Target-only] Epoch 3/50 – Loss: 0.4692  Val F1: 0.1404  ROC-AUC: 0.6992  PR-AUC: 0.1313
[Target-only] Epoch 4/50 – Loss: 0.4178  Val F1: 0.1592  ROC-AUC: 0.7160  PR-AUC: 0.1442
[Target-only] Epoch 5/50 – Loss: 0.3661  Val F1: 0.1284  ROC-AUC: 0.7101  PR-AUC: 0.1188
[Target-only] Epoch 6/50 – Loss: 0.3520  Val F1: 0.1293  ROC-AUC: 0.7234  PR-AUC: 0.1380
[Target-only] Epoch 7/50 – Loss: 0.3347  Val F1: 0.1647  ROC-AUC: 0.7159  PR-AUC: 0.2134
[Target-only] Epoch 8/50 – Loss: 0.3235  Val F1: 0.2037  ROC-AUC: 0.7303  PR-AUC: 0.2441
[Target-only] Epoch 9/50 – Loss: 0.3114  Val F1: 0.1512  ROC-AUC: 0.7455  PR-AUC: 0.1573
[Target-only] Epoch 10/50 – Loss: 0.2997  Val F1: 0.1850  ROC-AUC: 0.7325  PR-AUC: 0.1201
[Target-only] Epoch 11/50 – Loss: 0.2454  Val F1: 0.1881  ROC-AUC: 0.7619  PR-AUC: 0.1586
[Target-only] Epoch 12/50 – Loss: 0.2368  Val F1: 0.1611  ROC-AUC: 0.7610  PR-AUC: 0.1681
[Target-only] Epoch 13/50 – Loss: 0.2345  Val F1: 0.1654  ROC-AUC: 0.7387  PR-AUC: 0.2397
[Target-only] Epoch 14/50 – Loss: 0.2155  Val F1: 0.1722  ROC-AUC: 0.7430  PR-AUC: 0.2182
[Target-only] Epoch 15/50 – Loss: 0.2088  Val F1: 0.1818  ROC-AUC: 0.7540  PR-AUC: 0.1496
[Target-only] Epoch 16/50 – Loss: 0.2053  Val F1: 0.1839  ROC-AUC: 0.7400  PR-AUC: 0.1631
[Target-only] Epoch 17/50 – Loss: 0.2120  Val F1: 0.1622  ROC-AUC: 0.7282  PR-AUC: 0.1636
[Target-only] Epoch 18/50 – Loss: 0.1967  Val F1: 0.1517  ROC-AUC: 0.7400  PR-AUC: 0.2234
[Target-only] Epoch 19/50 – Loss: 0.1927  Val F1: 0.1681  ROC-AUC: 0.7392  PR-AUC: 0.1635
[Target-only] Epoch 20/50 – Loss: 0.1982  Val F1: 0.1732  ROC-AUC: 0.7434  PR-AUC: 0.1698
[Target-only] Epoch 21/50 – Loss: 0.1669  Val F1: 0.1719  ROC-AUC: 0.7491  PR-AUC: 0.1546
[Target-only] Epoch 22/50 – Loss: 0.1441  Val F1: 0.1630  ROC-AUC: 0.7436  PR-AUC: 0.2048
[Target-only] Epoch 23/50 – Loss: 0.1505  Val F1: 0.1875  ROC-AUC: 0.7427  PR-AUC: 0.1562
[Target-only] Epoch 24/50 – Loss: 0.1430  Val F1: 0.1719  ROC-AUC: 0.7439  PR-AUC: 0.1570
[Target-only] Epoch 25/50 – Loss: 0.1479  Val F1: 0.1549  ROC-AUC: 0.7504  PR-AUC: 0.1593
[Target-only] Epoch 26/50 – Loss: 0.1333  Val F1: 0.2178  ROC-AUC: 0.7502  PR-AUC: 0.1678
[Target-only] Epoch 27/50 – Loss: 0.1415  Val F1: 0.1955  ROC-AUC: 0.7608  PR-AUC: 0.1585
[Target-only] Epoch 28/50 – Loss: 0.1374  Val F1: 0.1884  ROC-AUC: 0.7522  PR-AUC: 0.1684
[Target-only] Epoch 29/50 – Loss: 0.1290  Val F1: 0.2034  ROC-AUC: 0.7482  PR-AUC: 0.1688
[Target-only] Epoch 30/50 – Loss: 0.1243  Val F1: 0.1833  ROC-AUC: 0.7515  PR-AUC: 0.1632
[Target-only] Epoch 31/50 – Loss: 0.1103  Val F1: 0.1951  ROC-AUC: 0.7592  PR-AUC: 0.1709
[Target-only] Epoch 32/50 – Loss: 0.1150  Val F1: 0.1786  ROC-AUC: 0.7502  PR-AUC: 0.1547
[Target-only] Epoch 33/50 – Loss: 0.1160  Val F1: 0.1905  ROC-AUC: 0.7570  PR-AUC: 0.1653
[Target-only] Epoch 34/50 – Loss: 0.1125  Val F1: 0.1835  ROC-AUC: 0.7561  PR-AUC: 0.1806
[Target-only] Epoch 35/50 – Loss: 0.1123  Val F1: 0.1951  ROC-AUC: 0.7549  PR-AUC: 0.1824
[Target-only] Epoch 36/50 – Loss: 0.1044  Val F1: 0.2222  ROC-AUC: 0.7474  PR-AUC: 0.1572
[Target-only] Epoch 37/50 – Loss: 0.1032  Val F1: 0.1800  ROC-AUC: 0.7397  PR-AUC: 0.1770
[Target-only] Epoch 38/50 – Loss: 0.1044  Val F1: 0.2281  ROC-AUC: 0.7546  PR-AUC: 0.1810
[Target-only] Epoch 39/50 – Loss: 0.0977  Val F1: 0.1869  ROC-AUC: 0.7520  PR-AUC: 0.1735
[Target-only] Epoch 40/50 – Loss: 0.0977  Val F1: 0.1887  ROC-AUC: 0.7598  PR-AUC: 0.1702
[Target-only] Epoch 41/50 – Loss: 0.0837  Val F1: 0.2182  ROC-AUC: 0.7610  PR-AUC: 0.1710
[Target-only] Epoch 42/50 – Loss: 0.0940  Val F1: 0.2000  ROC-AUC: 0.7592  PR-AUC: 0.1687
[Target-only] Epoch 43/50 – Loss: 0.0941  Val F1: 0.2041  ROC-AUC: 0.7617  PR-AUC: 0.1864
[Target-only] Epoch 44/50 – Loss: 0.0844  Val F1: 0.2136  ROC-AUC: 0.7503  PR-AUC: 0.1603
[Target-only] Epoch 45/50 – Loss: 0.0792  Val F1: 0.2083  ROC-AUC: 0.7530  PR-AUC: 0.1912
[Target-only] Epoch 46/50 – Loss: 0.0954  Val F1: 0.2316  ROC-AUC: 0.7564  PR-AUC: 0.1782
[Target-only] Epoch 47/50 – Loss: 0.0884  Val F1: 0.2022  ROC-AUC: 0.7557  PR-AUC: 0.1882
[Target-only] Epoch 48/50 – Loss: 0.0844  Val F1: 0.2075  ROC-AUC: 0.7584  PR-AUC: 0.1675
[Target-only] Epoch 49/50 – Loss: 0.0840  Val F1: 0.1978  ROC-AUC: 0.7555  PR-AUC: 0.1898
[Target-only] Epoch 50/50 – Loss: 0.0817  Val F1: 0.2062  ROC-AUC: 0.7578  PR-AUC: 0.1725
=== Target-only TEST performance ===
Test F1: 0.2588, ROC-AUC: 0.8407, PR-AUC: 0.2206
✅ 실험 완료: TOX21_ERa_BLA_Antagonist_ratio -> TOX21_ERa_BLA_Antagonist_viability [GIN_GCN]
